Certified by Founder Lodge
Panacea Venture
United States - Silicon Valley
INVESTOR
1 Disclosed Funding Rounds $59,500,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Panacea Venture is a life sciences venture capital firm with global vision and presence across three continents. The firm was founded in 2017 and is currently managing four funds investing in
| Company | Date | Round | Raised |
|---|---|---|---|
 Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
 OutSee |
June, 25 ,2025 | Seed | $2,452,266 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
